Author
University of California, San FranciscoORCID 0009-0002-5363-5563Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Naomi Yamamoto, Stephanie Dobersch, Tess M. Robertson…·Sita Kugel
This study shows HMGA2 in PDAC drives immunosuppressive TME by upregulating IL1α, which promotes CAFs and reduces CD8+ T cells, and blocking IL1 improves tumor control with KRAS inhibitors.
Tristan Courau, Rebecca Garrett Jaszczak, Bushra Samad…·Matthew F. Krummel
The paper compares mouse and human tumor microenvironments, identifying conserved and species-specific features in immune composition and gene expression programs.
Jillian M. Jespersen, Lia Avanesyan, Jean Publicover…·Jody L. Baron
The paper identifies shared mechanisms of HBsAg seroclearance using a mouse model and longitudinal PBMCs from CHB patients, showing CD4+ T cell activation is essential for clinical cure.